US$ 26.38
glp-1 receptor agonist type 1 diabetes trial liraglutide Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Receptor Agonists Explained for
Description
Boom in GLP-1 drugs augurs food industry disruption. Food Business News

It helps regulate blood sugar, slows stomach emptying and contributes to feelings of fullness

Tricare paid for
Curr Med Res Opin

doi: 10.3390/ijms24054687

This dual benefit of appetite control and blood sugar regulation is one reason why GLP-1 agonists are considered a promising treatment for both obesity and type 2 diabetes
